Shuttle Pharmaceuticals Holdings Inc (SHPH)
$1.7
+0.1
(+6.25%)▲
Performance
- $1.55$1.71$1.70
8.55%
Downside
Day's Volatility :9.09%
Upside
0.58%
- $1.28$5.80$1.70
24.71%
Downside
52 Weeks Volatility :77.94%
Upside
70.7%
Returns
| Period | Shuttle Pharmaceuticals Holdings Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -54.47% | 0.0% |
6 Months | -52.94% | 0.0% |
1 Year | -71.43% | 0.0% |
3 Years | -99.48% | -21.1% |
Highlights
Market Capitalization | 3.2M |
Book Value | $0.38 |
Earnings Per Share (EPS) | -3.44 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -61.69% |
Return On Equity TTM | -186.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -5.7M |
Diluted Eps TTM | -3.44 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Shuttle Pharmaceuticals Holdings Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Shuttle Pharmaceuticals Holdings Inc | -20.0% | -52.94% | -71.43% | -99.48% | -99.48% |
 Neurocrine Biosciences Inc. | -19.52% | -14.47% | 6.11% | 25.42% | 25.8% |
 Haleon Plc Spon Ads | 6.13% | 20.84% | 28.94% | 40.08% | 40.08% |
 Zoetis Inc. | 1.24% | 8.22% | 4.79% | -6.97% | 57.59% |
 Viatris Inc. | 1.56% | -2.49% | 20.51% | -15.59% | -28.09% |
 Catalent, Inc. | -0.03% | 5.46% | 22.27% | -56.31% | 16.24% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Shuttle Pharmaceuticals Holdings Inc | NA | NA | NA | 0.0 | -1.86 | -0.62 | NA | 0.38 |
Neurocrine Biosciences Inc. | 35.87 | 35.87 | 0.27 | 4.57 | 0.16 | 0.12 | NA | 24.87 |
Haleon Plc Spon Ads | 33.65 | 33.65 | 1.5 | 0.39 | 0.07 | 0.04 | 0.02 | 1.82 |
Zoetis Inc. | 37.47 | 37.47 | 2.63 | 5.82 | 0.49 | 0.14 | 0.01 | 10.94 |
Viatris Inc. | 224.4 | NA | 0.07 | 2.68 | -0.03 | 0.03 | 0.04 | 16.36 |
Catalent, Inc. | 211.02 | NA | 2.85 | 0.2 | -0.25 | 0.0 | NA | 19.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Shuttle Pharmaceuticals Holdings Inc | NA | $3.2M | -99.48% | NA | 0.0% |
Neurocrine Biosciences Inc. | Buy | $12.2B | 25.8% | 35.87 | 16.0% |
Haleon Plc Spon Ads | Buy | $47.5B | 40.08% | 33.65 | 9.66% |
Zoetis Inc. | Buy | $86.4B | 57.59% | 37.47 | 26.29% |
Viatris Inc. | Hold | $13.5B | -28.09% | 224.4 | -4.24% |
Catalent, Inc. | Hold | $10.8B | 16.24% | 211.02 | -23.81% |
Insights on Shuttle Pharmaceuticals Holdings Inc
Vs HLN
In the last 1 year, Haleon Plc Spon Ads has given 28.9% return, outperforming this stock by 100.3%
Institutional Holdings
Geode Capital Management, LLC
0.22%UBS Group AG
0.01%
Company Information
Organization | Shuttle Pharmaceuticals Holdings Inc |
Employees | 8 |
CEO | Dr. Anatoly Dritschilo M.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$1.70
+6.25%
Keyarch Acquisition Corp
$1.70
+6.25%
Connexa Sports Technologies Inc
$1.70
+6.25%
Us Value Etf
$1.70
+6.25%
First Wave Biopharma Inc
$1.70
+6.25%
Global X Msci Next Emerging
$1.70
+6.25%
Fat Projects Acquisition Corp
$1.70
+6.25%
Capital Link Global Fintech
$1.70
+6.25%
Applied Uv Inc
$1.70
+6.25%